Home

Tutoring

Subjects

Live Classes

Study Coach

Essay Review

On-Demand Courses

Colleges

Games


Sign up

Log in

Opening subject page...

Loading your content

← Back to quizzes

USMLE Step 1 Quiz

USMLE Step 1 Quiz: Hypersensitivity Reactions

Practice Hypersensitivity Reactions in USMLE Step 1 with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

Question 1 / 20

0 of 20 answered

A 9-year-old boy develops an intensely pruritic, linear vesicular rash 2 days after hiking and brushing against poison ivy; vitals are normal and CBC is normal. Which mechanism best describes the patient’s symptoms?

Select an answer to continue

What this quiz covers

This quiz focuses on Hypersensitivity Reactions, giving you a quick way to practice the rules, question types, and explanations that matter most for USMLE Step 1.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A 9-year-old boy develops an intensely pruritic, linear vesicular rash 2 days after hiking and brushing against poison ivy; vitals are normal and CBC is normal. Which mechanism best describes the patient’s symptoms?

  1. Type I: Allergen cross-links IgE on mast cells causing immediate wheal-and-flare and possible anaphylaxis within minutes
  2. Type II: IgG binds to cell-surface antigens causing complement activation and cell destruction with a positive Coombs test
  3. Type IV: Sensitized T cells mediate delayed inflammation and epidermal damage 48–72 hours after exposure to urushiol (correct answer)
  4. Type III: Immune complexes deposit in small vessels causing palpable purpura, arthralgia, and low complement
  5. Nonimmune: Irritant dermatitis from acids causing immediate burning pain without prior sensitization or immune memory

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type IV hypersensitivity reaction, characterized by delayed vesicular rash after poison ivy exposure. Choice C is correct because it accurately describes the mechanism of a type IV hypersensitivity reaction, as supported by the vignette details including onset 2 days post-exposure. Choice E is incorrect because it confuses nonimmune irritant effects with T-cell mediated responses, which often occurs when students misinterpret timing of symptom onset. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 2

A 30-year-old man receives a transfusion and develops fever, flank pain, and hemoglobinuria within 1 hour; labs show low haptoglobin and rising bilirubin. Which mechanism best describes the patient’s symptoms?

  1. Type I: IgE-mediated mast-cell activation causing bronchospasm and urticaria without hemoglobinuria or anemia
  2. Type II: Preformed IgM/IgG against donor RBC antigens activates complement, causing intravascular hemolysis and hemoglobinuria (correct answer)
  3. Type III: Immune complexes deposit in joints and kidneys causing low complement and delayed symptoms over days
  4. Type IV: Cytotoxic T cells attack transfused leukocytes causing delayed rash and mucosal lesions
  5. Nonimmune: Mechanical hemolysis from small-gauge needles causing mild anemia without complement activation

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by acute hemolytic transfusion reaction with hemoglobinuria. Choice B is correct because it accurately describes the mechanism of a type II hypersensitivity reaction, as supported by the vignette details including low haptoglobin within 1 hour. Choice A is incorrect because it confuses type I allergic responses with transfusion-related hemolysis, which often occurs when students misinterpret intravascular symptoms. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 3

A 33-year-old man develops painful oral ulcers and targetoid skin lesions 2 weeks after starting lamotrigine; biopsy shows epidermal necrosis with lymphocytic infiltration. Which mechanism best describes the patient’s symptoms?

  1. Type I: IgE cross-linking triggers mast-cell degranulation causing immediate urticaria and bronchospasm after drug exposure
  2. Type II: IgG binds to cell-surface antigens causing complement-mediated cytotoxicity and a positive direct Coombs test
  3. Type III: Immune complexes deposit in vessels causing palpable purpura, arthralgia, and low complement levels
  4. Type IV: Cytotoxic T cells induce keratinocyte apoptosis, producing delayed severe mucocutaneous reactions after sensitization (correct answer)
  5. Nonimmune: Histamine release from opioids causing flushing and pruritus without epidermal necrosis or mucosal involvement

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type IV hypersensitivity reaction, characterized by delayed mucocutaneous reaction like SJS from lamotrigine. Choice D is correct because it accurately describes the mechanism of a type IV hypersensitivity reaction, as supported by the vignette details including onset 2 weeks later and biopsy findings. Choice A is incorrect because it confuses type I immediate responses with delayed T-cell mediated apoptosis, which often occurs when students misinterpret reaction timing. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 4

A 47-year-old woman develops fatigue and pallor after starting a new medication; labs show hemoglobin 7.8 g/dL, reticulocytes 9%, and a positive direct Coombs test. Which of the following best describes the mechanism of the patient’s symptoms?

  1. Antibodies bind RBC surface antigens, leading to complement activation or splenic clearance and hemolytic anemia with Coombs positivity (correct answer)
  2. Allergen-specific IgE triggers mast-cell degranulation, causing immediate bronchospasm and urticaria with elevated serum tryptase
  3. Immune complexes deposit in glomeruli, causing low complement, proteinuria, and granular immunofluorescence patterns
  4. Th1-mediated macrophage activation causes delayed induration and granuloma formation after antigen exposure over 48–72 hours
  5. Direct marrow suppression reduces erythropoiesis, causing low reticulocytes and pancytopenia rather than immune hemolysis

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by drug-induced hemolytic anemia with positive Coombs and high reticulocytes. Choice A is correct because it accurately describes the mechanism of a type II hypersensitivity reaction, as supported by the vignette details including fatigue and low hemoglobin. Choice E is incorrect because it confuses nonimmune suppression with immune hemolysis, which often occurs when students misinterpret reticulocyte response. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 5

A 58-year-old man develops jaundice and anemia after starting methyldopa; labs show elevated LDH, low haptoglobin, and a positive direct Coombs test. Which laboratory finding supports the diagnosis of a type II hypersensitivity reaction?

  1. Elevated serum tryptase within 2 hours of symptoms, reflecting mast-cell degranulation after IgE cross-linking
  2. Positive direct antiglobulin test demonstrating antibodies bound to RBCs, consistent with immune-mediated hemolysis (correct answer)
  3. Low C3 and C4 with granular immune deposits in glomeruli, consistent with immune complex deposition disease
  4. Delayed induration at 72 hours after skin testing, consistent with T-cell mediated delayed hypersensitivity
  5. Increased urine eosinophils with acute interstitial nephritis, consistent with drug hypersensitivity affecting tubules

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by drug-induced hemolytic anemia with positive Coombs. Choice B is correct because it accurately describes the laboratory finding supporting a type II hypersensitivity reaction, as supported by the vignette details including jaundice and low haptoglobin. Choice C is incorrect because it confuses type III immune complexes with type II direct antibody binding, which often occurs when students misinterpret Coombs test significance. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 6

A 25-year-old man develops anaphylaxis minutes after IV contrast; he had a similar reaction previously and now has elevated tryptase. Which of the following best describes the mechanism of the patient’s symptoms?

  1. Allergen cross-linking of IgE on mast cells triggers degranulation, causing hypotension and bronchospasm with elevated tryptase (correct answer)
  2. IgG binds to RBC antigens causing complement-mediated hemolysis with hemoglobinuria and a positive direct Coombs test
  3. Immune complexes deposit in tissues causing fever and arthralgias days later with low complement and vasculitis
  4. T-cell mediated keratinocyte apoptosis causes delayed mucosal erosions and epidermal necrosis after 1–3 weeks
  5. Direct endothelial toxicity causes hypotension without mast-cell mediators, immune sensitization, or elevated tryptase levels

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type I hypersensitivity reaction, characterized by anaphylaxis to IV contrast with elevated tryptase and prior history. Choice A is correct because it accurately describes the mechanism of a type I hypersensitivity reaction, as supported by the vignette details including rapid onset. Choice D is incorrect because it confuses type IV delayed reactions with immediate IgE responses, which often occurs when students misinterpret tryptase elevation. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 7

A 60-year-old woman develops petechiae and gingival bleeding 5 days after starting trimethoprim-sulfamethoxazole; platelets are 8,000/µL and hemoglobin is normal. What type of hypersensitivity reaction is most likely responsible?

  1. Type I: IgE-mediated mast-cell activation causing urticaria and bronchospasm within minutes of drug exposure
  2. Type II: Drug-dependent antibodies target platelets, causing immune thrombocytopenia and bleeding with severe thrombocytopenia (correct answer)
  3. Type III: Immune complex deposition causing fever, arthralgia, and low complement several days after exposure
  4. Type IV: T-cell mediated dermatitis causing localized vesicles at contact sites 48–72 hours after exposure
  5. Nonimmune: Bone marrow suppression causing pancytopenia with low platelets, anemia, and neutropenia simultaneously

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by drug-induced thrombocytopenia with bleeding. Choice B is correct because it accurately describes the mechanism of a type II hypersensitivity reaction, as supported by the vignette details including isolated low platelets. Choice E is incorrect because it confuses nonimmune marrow suppression with antibody-mediated destruction, which often occurs when students misinterpret selective cytopenia. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 8

A 44-year-old woman develops fever, urticaria, arthralgias, and lymphadenopathy 8 days after starting cefaclor; C3 is low and urinalysis shows mild proteinuria. What type of hypersensitivity reaction is most likely responsible?

  1. Type I: IgE-mediated mast-cell activation causing immediate bronchospasm and hypotension within minutes of exposure
  2. Type II: Antibody-mediated cytotoxicity against RBCs causing hemolysis and a positive direct Coombs test
  3. Type III: Immune complex deposition causing serum sickness features with hypocomplementemia and systemic symptoms (correct answer)
  4. Type IV: T-cell mediated contact dermatitis causing localized vesicles and pruritus 48–72 hours after exposure
  5. Nonimmune: Viral exanthem causing rash and fever without complement consumption or immune complex formation

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type III hypersensitivity reaction, characterized by serum sickness from cefaclor with low C3. Choice C is correct because it accurately describes the mechanism of a type III hypersensitivity reaction, as supported by the vignette details including fever and arthralgias 8 days later. Choice D is incorrect because it confuses type IV contact dermatitis with systemic immune complex disease, which often occurs when students misinterpret complement levels. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 9

A 38-year-old woman with SLE has worsening proteinuria; kidney biopsy shows granular deposits of IgG and C3 along the glomerular basement membrane. Which laboratory finding supports the diagnosis of a type III hypersensitivity reaction?

  1. Low serum complement levels due to consumption during immune complex activation, consistent with type III hypersensitivity (correct answer)
  2. Positive direct Coombs test demonstrating antibodies bound to RBCs, consistent with autoimmune hemolytic anemia
  3. Elevated serum tryptase shortly after symptoms, consistent with mast-cell degranulation in anaphylaxis
  4. Delayed induration 72 hours after PPD placement, consistent with T-cell mediated delayed hypersensitivity
  5. Elevated creatine kinase with muscle weakness, consistent with inflammatory myopathy rather than immune complex disease

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type III hypersensitivity reaction, characterized by immune complex deposition in SLE nephritis with granular deposits. Choice A is correct because it accurately describes the laboratory finding supporting a type III hypersensitivity reaction, as supported by the vignette details including worsening proteinuria. Choice B is incorrect because it confuses type II hemolysis with type III complexes, which often occurs when students misinterpret biopsy patterns. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 10

A 62-year-old man develops anemia and mild jaundice after 2 weeks of ceftriaxone; labs show elevated indirect bilirubin and a positive direct Coombs test. What type of hypersensitivity reaction is most likely responsible?

  1. Type I: IgE-mediated mast-cell degranulation causing immediate urticaria and airway edema minutes after exposure
  2. Type II: Antibody-mediated destruction of RBCs triggered by drug exposure, producing Coombs-positive hemolytic anemia (correct answer)
  3. Type III: Immune complex deposition causing fever, arthralgia, and low complement with delayed systemic symptoms
  4. Type IV: T-cell mediated dermatitis causing localized rash 48–72 hours after contact with an allergen
  5. Nonimmune: Microangiopathic hemolysis causing schistocytes and thrombocytopenia without a positive Coombs test

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by drug-induced hemolytic anemia from ceftriaxone with positive Coombs. Choice B is correct because it accurately describes the mechanism of a type II hypersensitivity reaction, as supported by the vignette details including anemia after 2 weeks. Choice E is incorrect because it confuses nonimmune hemolysis with antibody-mediated destruction, which often occurs when students misinterpret Coombs positivity. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 11

A 46-year-old man with SLE has pleuritic chest pain and worsening edema; urinalysis shows proteinuria and RBC casts, and C3 is low. Which of the following best describes the mechanism of the patient’s symptoms?

  1. Immune complex deposition activates complement, recruiting neutrophils and causing tissue inflammation in kidneys and serosal surfaces (correct answer)
  2. IgE-mediated mast-cell degranulation causes immediate bronchospasm and urticaria after allergen exposure with elevated tryptase
  3. Antibody binding to RBC antigens causes complement-mediated hemolysis with positive direct Coombs and dark urine
  4. T-cell mediated delayed dermatitis causes linear vesicles 48–72 hours after plant exposure with normal complement levels
  5. Direct podocyte toxicity causes proteinuria without immune deposits, complement consumption, or systemic inflammatory findings

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type III hypersensitivity reaction, characterized by immune complex deposition in SLE with low C3 and renal involvement. Choice A is correct because it accurately describes the mechanism of a type III hypersensitivity reaction, as supported by the vignette details including proteinuria and pleuritis. Choice C is incorrect because it confuses type II hemolysis with immune complex disease, which often occurs when students misinterpret systemic vs. cell-specific injury. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 12

A 48-year-old woman with known SLE has new joint pain and foamy urine; urinalysis shows protein 3+ and RBC casts, and C3/C4 are low. What type of hypersensitivity reaction is most likely responsible?

  1. Type I: IgE-mediated mast-cell degranulation causing acute urticaria, bronchospasm, and hypotension minutes after exposure
  2. Type II: Antibodies against basement membrane causing linear immunofluorescence and rapidly progressive glomerulonephritis
  3. Type IV: T-cell mediated granulomatous inflammation with caseating necrosis and delayed induration after antigen challenge
  4. Type III: Immune complex deposition activates complement, leading to inflammation in joints and kidneys with low complement levels (correct answer)
  5. Nonimmune: Direct podocyte injury from diabetes causing proteinuria without immune deposits or complement consumption

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type III hypersensitivity reaction, characterized by immune complex deposition in SLE leading to low complement and renal involvement. Choice D is correct because it accurately describes the mechanism of a type III hypersensitivity reaction, as supported by the vignette details including proteinuria and low C3/C4. Choice B is incorrect because it confuses type II antibody-mediated injury with immune complex disease, which often occurs when students misinterpret immunofluorescence patterns. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 13

A 52-year-old man has hemoptysis and dyspnea; urinalysis shows RBC casts and creatinine is elevated. Anti-GBM antibodies are positive and immunofluorescence shows linear IgG. What type of hypersensitivity reaction is most likely responsible?

  1. Type III: Immune complexes deposit in glomeruli causing granular immunofluorescence and hypocomplementemia with arthralgias
  2. Type I: IgE-mediated mast-cell degranulation causing immediate wheal-and-flare and bronchospasm after allergen exposure
  3. Type II: IgG targets basement membrane antigens, causing complement-mediated injury with linear immunofluorescence in kidney and lung (correct answer)
  4. Type IV: Th1-mediated macrophage activation causing granulomas and delayed induration after a skin test
  5. Nonimmune: Hypertensive nephrosclerosis causing progressive renal failure without antibodies or immunofluorescence staining

Explanation: This question tests understanding of hypersensitivity reactions in immunology, specifically the mechanisms and clinical presentations of types I-IV. Hypersensitivity reactions are classified into four types based on the immune mechanism involved, ranging from immediate IgE-mediated responses to delayed T-cell mediated reactions. In this clinical vignette, the patient's symptoms and laboratory findings suggest a type II hypersensitivity reaction, characterized by anti-GBM disease with linear immunofluorescence. Choice C is correct because it accurately describes the mechanism of a type II hypersensitivity reaction, as supported by the vignette details including hemoptysis and positive anti-GBM antibodies. Choice A is incorrect because it confuses type III immune complexes with type II direct antibody binding, which often occurs when students misinterpret immunofluorescence patterns. To improve understanding, students should focus on the key characteristics and mechanisms of each hypersensitivity type, practice linking clinical presentations with pathophysiological processes, and review case studies that highlight common errors and misconceptions.

Question 14

A 32-year-old medical student undergoes screening for latent tuberculosis infection. Forty-eight hours after intradermal injection of purified protein derivative (PPD), the test site shows a 10-mm area of firm induration. Which cytokines most directly mediated the cellular response responsible for this finding?

  1. Interleukin-2 and interferon-γ released by Th1 lymphocytes (correct answer)
  2. Interleukin-4 and interleukin-5 secreted by Th2 lymphocytes
  3. Interleukin-10 and transforming growth factor-β from regulatory T cells
  4. Histamine and tryptase liberated from mast-cell granules

Explanation: When you encounter questions about tuberculin skin tests (TST), think about delayed-type hypersensitivity reactions and the specific immune cells involved. The PPD test measures your body's cell-mediated immune response to tuberculosis antigens, which occurs through a well-defined pathway. The 10-mm induration at 48-72 hours represents a classic Type IV delayed-type hypersensitivity reaction. Here's what happens: when PPD antigens are injected, memory T cells that were previously sensitized to TB antigens become activated. These are specifically Th1 cells, which release interleukin-2 (IL-2) and interferon-γ (IFN-γ). IL-2 promotes T cell proliferation and activation, while IFN-γ activates macrophages, causing them to accumulate at the injection site. The firm induration you feel is literally a collection of activated immune cells creating localized inflammation. Choice A correctly identifies this Th1-mediated response. Choice B describes Th2 responses, which involve IL-4 and IL-5 and are associated with allergic reactions and parasitic infections, not TB immunity. Choice C represents regulatory T cell function (IL-10 and TGF-β), which actually suppresses immune responses rather than creating the inflammation seen in PPD tests. Choice D describes immediate hypersensitivity (Type I), where mast cells release histamine and tryptase within minutes to hours, not the delayed response seen here. Remember this pattern: delayed induration (48-72 hours) always indicates Th1-mediated immunity. This concept applies beyond TB testing to other delayed hypersensitivity reactions you'll encounter on Step 1, including contact dermatitis and organ transplant rejection.

Question 15

A 17-year-old girl with atopic asthma is exposed to cat dander while visiting a friend. Within minutes she develops wheezing that persists for several hours despite initial use of a short-acting β₂-agonist. Which mediator released from mast cells is primarily responsible for the sustained bronchoconstriction observed several hours after the exposure?

  1. Leukotriene C₄, which causes prolonged airway smooth-muscle contraction (correct answer)
  2. Complement fragment C5a, which is strongly chemotactic for neutrophils
  3. Prostacyclin (PGI₂), which promotes vasodilation and inhibits platelet aggregation
  4. Interferon-α, an antiviral cytokine released by virally infected cells

Explanation: When you encounter questions about asthma exacerbations, think about the biphasic nature of allergic reactions: immediate symptoms from preformed mediators, followed by sustained inflammation from newly synthesized mediators. This patient's prolonged bronchoconstriction hours after cat dander exposure represents the late-phase asthmatic response. While initial wheezing comes from preformed mediators like histamine (which β₂-agonists effectively counter), the sustained symptoms result from leukotrienes synthesized by mast cells through the arachidonic acid pathway. Leukotriene C₄ (LTC₄) is the key culprit here—it's 1000 times more potent than histamine at causing bronchoconstriction and produces prolonged airway smooth muscle contraction that's resistant to β₂-agonists. This explains why her wheezing persisted despite using her rescue inhaler. Looking at the wrong answers: (B) Complement fragment C5a does attract neutrophils, but it's not a primary mast cell product in allergic asthma, and neutrophils aren't the main players in this type of reaction. (C) Prostacyclin (PGI₂) actually opposes bronchoconstriction—it causes vasodilation and bronchodilation, so it wouldn't explain sustained wheezing. (D) Interferon-α is an antiviral cytokine unrelated to allergic reactions and isn't released by mast cells. Remember this pattern: immediate asthma symptoms respond well to β₂-agonists, but leukotriene-mediated late-phase reactions often require anti-inflammatory treatment like corticosteroids or leukotriene receptor antagonists (like montelukast). This is why some asthmatic patients need controller medications beyond rescue inhalers.

Question 16

One week after starting high-dose intravenous penicillin for neurosyphilis, a 34-year-old man develops fatigue and dark urine. Laboratory testing reveals a positive direct Coombs test and a falling hemoglobin level. Which type of hypersensitivity reaction best describes the pathogenesis of this patient’s anemia?

  1. IgG-mediated cytotoxicity directed against drug-modified erythrocyte membrane proteins (type II hypersensitivity) (correct answer)
  2. Immune complex deposition in small vessels with complement activation (type III hypersensitivity)
  3. Cross-linking of drug-specific IgE on mast cells causing systemic anaphylaxis (type I hypersensitivity)
  4. Delayed cytotoxic T-cell response against erythrocyte neoantigens (type IV hypersensitivity)

Explanation: When you encounter a patient developing anemia with a positive direct Coombs test after drug administration, think about drug-induced hemolytic anemia and the hypersensitivity mechanisms that cause it. This patient's presentation—fatigue, dark urine (hemoglobinuria), positive direct Coombs test, and falling hemoglobin after penicillin—is classic for drug-induced hemolytic anemia. The positive direct Coombs test indicates antibodies are bound to the patient's red blood cells. Answer A correctly identifies this as type II hypersensitivity, where IgG antibodies target drug-modified erythrocyte membrane proteins. Penicillin can bind to red blood cell membranes, creating hapten-protein complexes that the immune system recognizes as foreign, leading to antibody production and complement-mediated hemolysis. Answer B describes type III hypersensitivity involving immune complex deposition, which typically causes vasculitis or serum sickness-like symptoms, not isolated hemolytic anemia with positive Coombs test. Answer C represents type I hypersensitivity (anaphylaxis), which would present acutely with respiratory distress, hypotension, and urticaria—not delayed hemolysis. Answer D describes type IV hypersensitivity, a T-cell mediated delayed response that doesn't involve antibody binding to red cells and wouldn't cause a positive Coombs test. For USMLE Step 1, remember that drug-induced hemolytic anemia with positive Coombs test always points to type II hypersensitivity. The key clue is the combination of hemolysis plus positive direct Coombs test—this indicates antibodies are attached to red blood cells, which is the hallmark of type II reactions.

Question 17

Patch testing is used to confirm allergy to nickel in patients with suspected contact dermatitis. The test site is examined 48 hours after application of a nickel-impregnated disk. The delay before reading the test is necessary because the reaction depends on which of the following processes?

  1. Time required for cutaneous dendritic cells to present nickel–protein complexes to memory T cells and recruit macrophages (correct answer)
  2. Delay needed for complement-fixing immune complexes to deposit in dermal vessels
  3. Interval required for B cells to undergo class switching from IgM to IgE production
  4. Time necessary for eosinophils to degranulate and release major basic protein causing tissue necrosis

Explanation: When you encounter patch testing questions, think about hypersensitivity reactions and their time courses. Contact dermatitis from nickel represents a classic Type IV (delayed-type) hypersensitivity reaction, which explains why the test requires a 48-hour delay. The correct answer is (A) because nickel contact dermatitis involves a complex cellular immune response. When nickel contacts skin, it acts as a hapten, binding to skin proteins to form immunogenic complexes. Cutaneous dendritic cells (particularly Langerhans cells) must first capture and process these nickel-protein complexes, then migrate to regional lymph nodes to present antigens to T cells. Once activated, memory T cells return to the skin and recruit macrophages, creating the characteristic inflammatory response. This entire cellular cascade requires 24-48 hours to develop visibly. Choice (B) describes Type III hypersensitivity (immune complex disease), which involves antibody-antigen complexes depositing in vessels—not the mechanism in contact dermatitis. Choice (C) represents Type I hypersensitivity (immediate), involving IgE and occurring within minutes to hours, not days. Choice (D) also suggests immediate hypersensitivity with eosinophil degranulation, which doesn't match the delayed timeframe of patch testing. Study tip: Remember the "4 types, 4 timeframes" pattern: Type I (immediate/minutes), Type II (hours), Type III (hours to days), and Type IV (days). Contact dermatitis is always Type IV, requiring T-cell activation and recruitment—hence the delay in patch testing. When you see "48-72 hour delay" in immunology questions, think cellular immunity and Type IV reactions.

Question 18

A 60-year-old farmer presents with progressive shortness of breath and dry cough. He reports that symptoms worsen several hours after working in his moldy barn and improve on weekends away from the farm. Chest CT shows patchy, nodular interstitial infiltrates. Precipitating antibodies against thermophilic actinomycetes are detected in serum. Which pattern best describes the immunopathogenesis of this patient’s lung disease?

  1. Initial immune complex–mediated injury followed by T-cell–driven delayed inflammation, representing a combined type III and type IV hypersensitivity reaction (correct answer)
  2. Immediate mast-cell degranulation after antigen exposure consistent with an isolated type I hypersensitivity reaction
  3. Autoantibody binding to alveolar basement membrane causing a pure type II hypersensitivity reaction
  4. Nonimmune toxic injury to pneumocytes from inhaled organic dust particles

Explanation: When you encounter a patient with respiratory symptoms that worsen hours after antigen exposure and improve with avoidance, think hypersensitivity pneumonitis (farmer's lung). This condition involves a complex immune response to inhaled organic antigens like thermophilic actinomycetes found in moldy hay. The correct answer is A because hypersensitivity pneumonitis demonstrates a biphasic immune response. Initially, inhaled antigens form immune complexes that deposit in alveolar walls, triggering complement activation and neutrophil recruitment (type III hypersensitivity). This explains the 4-6 hour delay in symptom onset. Subsequently, sensitized T-cells recognize the antigen and orchestrate chronic granulomatous inflammation (type IV hypersensitivity), leading to the progressive fibrotic changes seen on CT. Option B is wrong because type I reactions cause immediate symptoms (within minutes), not the delayed onset described here. While some patients may have immediate symptoms, the predominant pathophysiology involves types III and IV. Option C describes Goodpasture syndrome, where autoantibodies target basement membranes. This patient has precipitating antibodies against external antigens, not autoantibodies. Option D misses the immunologic basis entirely. The presence of precipitating antibodies and the pattern of exposure-related symptoms clearly indicate an immune-mediated process, not simple toxic injury. Remember: Hypersensitivity pneumonitis always involves delayed symptoms (hours after exposure) and combines immune complex formation with T-cell-mediated inflammation. The temporal pattern and precipitating antibodies are key diagnostic clues that point to this dual mechanism.

Question 19

During a company picnic, a 25-year-old woman with a history of severe peanut allergy accidentally eats a cookie that contains peanut flour. Within minutes she develops generalized urticaria, bronchospasm, and hypotension. Which of the following immunologic events occurs first and is primarily responsible for initiating these acute findings?

  1. Cross-linking of allergen-specific IgE bound to high-affinity FcεRI receptors on mast cell membranes, rapidly triggering degranulation (correct answer)
  2. Activation of complement by IgM immune complexes with formation of the membrane-attack complex on vascular endothelial cells
  3. Deposition of circulating IgG–antigen immune complexes in post-capillary venules with subsequent neutrophil recruitment
  4. Sensitization and clonal expansion of CD8⁺ cytotoxic T lymphocytes recognizing peanut-derived peptides presented on MHC class I molecules

Explanation: When you encounter a question about immediate allergic reactions with symptoms like urticaria, bronchospasm, and hypotension within minutes of exposure, you're dealing with Type I hypersensitivity (anaphylaxis). The key is understanding the sequence of immunologic events and which happens first to trigger the cascade. The correct answer is A because anaphylaxis begins when peanut allergens cross-link with allergen-specific IgE antibodies that are already bound to high-affinity FcεRI receptors on mast cell and basophil surfaces. This cross-linking immediately triggers degranulation, releasing preformed mediators like histamine, tryptase, and chemotactic factors within seconds to minutes. These mediators directly cause vasodilation (hypotension), increased vascular permeability (urticaria), and smooth muscle contraction (bronchospasm). Option B describes Type II hypersensitivity involving complement activation and membrane attack complexes, which takes longer to develop and isn't the primary mechanism in food allergies. Option C represents Type III hypersensitivity with immune complex deposition and neutrophil recruitment, which typically occurs hours to days after exposure and involves different antibody classes. Option D describes Type IV (delayed-type) hypersensitivity mediated by T-cells, which takes 24-72 hours to manifest and wouldn't explain the immediate symptoms. Remember that anaphylaxis requires prior sensitization—the patient already has circulating IgE antibodies from previous peanut exposure. For USMLE Step 1, always associate immediate reactions (minutes) with Type I hypersensitivity and mast cell degranulation, while delayed reactions point to other hypersensitivity types.

Question 20

A 29-year-old man presents with hematuria and hemoptysis. Chest imaging shows bilateral alveolar infiltrates, and renal biopsy demonstrates segmental necrosis with linear immunofluorescent staining for IgG along the glomerular basement membrane. Which of the following immune mechanisms is responsible for this patient’s disease?

  1. Autoantibodies (IgG) bind type IV collagen in basement membranes, fix complement, and cause cytotoxic damage (type II hypersensitivity) (correct answer)
  2. Circulating antigen–antibody complexes deposit in glomeruli, activate complement, and incite inflammation (type III hypersensitivity)
  3. Allergen-specific IgE on mast cells is cross-linked, leading to massive histamine release (type I hypersensitivity)
  4. Sensitized Th1 lymphocytes recruit macrophages that mediate delayed granulomatous inflammation (type IV hypersensitivity)

Explanation: When you encounter a case combining pulmonary-renal syndrome with linear immunofluorescence on kidney biopsy, think Goodpasture syndrome and hypersensitivity reaction classification. This patient's presentation is classic for Goodpasture syndrome: simultaneous lung and kidney involvement with the pathognomonic finding of linear IgG staining along the glomerular basement membrane (GBM). This linear pattern indicates antibodies directly binding to basement membrane components, specifically type IV collagen (α3 chain). These anti-GBM antibodies fix complement and recruit inflammatory cells, causing direct cytotoxic damage to both pulmonary and glomerular basement membranes. This mechanism defines type II hypersensitivity, making A correct. B describes type III hypersensitivity, which would show granular (not linear) immunofluorescence from immune complex deposition. This pattern is seen in conditions like lupus nephritis or post-infectious glomerulonephritis. C represents type I hypersensitivity (immediate allergic reactions). While mast cells and histamine can contribute to some renal diseases, this IgE-mediated mechanism doesn't explain the linear GBM staining or the chronic pulmonary-renal syndrome pattern. D describes type IV hypersensitivity (delayed-type), a T-cell mediated response causing granulomatous inflammation. This wouldn't produce the antibody-mediated linear immunofluorescence pattern characteristic of this case. Study tip: Linear immunofluorescence = direct antibody binding (type II), while granular patterns = immune complex deposition (type III). The immunofluorescence pattern is often the key distinguishing feature between these two mechanisms on USMLE questions.